...
首页> 外文期刊>Letters in drug design & discovery >Synthesis, Characterization, Antimicrobial, Anti-tubercular, Antioxidant Activities and Docking Simulations of Derivatives of 2-(pyridin-3-yl)-1H-benzo[d]imidazole and 1,3,4-Oxadiazole Analogy
【24h】

Synthesis, Characterization, Antimicrobial, Anti-tubercular, Antioxidant Activities and Docking Simulations of Derivatives of 2-(pyridin-3-yl)-1H-benzo[d]imidazole and 1,3,4-Oxadiazole Analogy

机译:2-(Pyridin-3-基)-1H-苯并[D]咪唑和1,3,4-氧代唑类比的合成,表征,抗微生物,抗氧化活性,抗氧化活性和对接模拟的衍生物和1,3,4-氧代唑类比

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Antimicrobial Resistance (AMR) and Tuberculosis (TB) are global concern. According to the WHO fact sheet on tuberculosis, in 2017, 10 million people fell ill with TB, and 1.6 million including 230,000 children died from the disease. There is a critical need of design and development of novel chemotherapeutic agents to combat the emergence and increasing prevalence of resistant pathogens. In the present study, a new series of 1,3,4-oxadiazoles incorporating benzimidazole and pyridine scaffolds in a single molecular framework has been reported.
机译:背景:抗微生物抗性(AMR)和结核病(TB)是全球担忧。 根据THEBBERCULIS的世界卫生组织的事实表,2017年,1000万人与TB跌幅,其中160万人,其中包括230,000名儿童死于该疾病。 新型化学治疗剂的设计和开发存在危急需要,以应对抗性病原体的出现和越来越普遍。 在本研究中,已经报道了一种新的1,3,4-氧基Zoles,其在单个分子框架中掺入苯并咪唑和吡啶支架中的一种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号